Google’s Quantum Computing Breakthrough… And Health Insurers In The Spotlight 12/10/24

10 Dec 2024 · 44 min

Ask about this episode

Ask anything about it. ChatGPT or Claude reads this page and answers with the times it was said.

Connect VO and ask about every podcast you hear, including the moments you saved. Add to ChatGPT · Add to Claude

In short

Podcast Episode Summary

Podcast Information

  • Title: CNBC's "Fast Money"
  • Host: Melissa Lee
  • Episode Title: Google’s Quantum Computing Breakthrough… And Health Insurers In The Spotlight
  • Air Date: 12/10/24
  • Description: A discussion on Google's recent advances in quantum computing, health insurance sector scrutiny following the murder investigation of a UnitedHealthcare CEO, and various other market updates.

---

Key Highlights

Google's Quantum Computing Breakthrough

  • Significant Announcement: Google unveiled its quantum chip, "Willow," capable of performing calculations that would take about 10 septillion years in under five minutes.
  • Market Impact: Alphabet's shares surged over 5%, adding nearly $120 billion to its market cap.
  • Expert Opinions:
  • Guy Adami: Suggested that the breakthrough indicates Google is not as far behind competitors as previously thought. He noted the importance of Google's valuation amidst its core business strengths.
  • Steve Grasso: Raised concerns about the commercial application of quantum computing and its ability to monetize.
  • Julie Beal: Highlighted that this technology is in its early stages and that the market's reaction might reflect a revaluation of Google's potential in AI and cloud computing.

Health Insurance Sector Scrutiny

  • Murder Case Update: Coverage of the suspected shooter in the murder of UnitedHealthcare’s CEO, Brian Thompson, who had a manifesto criticizing the health care industry.
  • Market Implications: The incident has sparked concerns about scrutiny in the health insurance sector and could lead to regulatory changes or increased public backlash against these firms.
  • John Ransom's Insights:
  • Emphasized the industry's growing unpopularity and how it might face legislative risks due to high medical costs and claims denials.
  • Discussed the potential consequences of forced transparency regarding claim denials and how that could impact business operations.

Other Notable Market Updates

  • Walgreens: In talks for a potential private equity deal, highlighting the challenges and opportunities facing the pharmacy chain.
  • Boeing: Restarted production of the 737 MAX, marking a significant step in recovery.
  • Amazon: Officially launched its drone delivery program in Phoenix, aiming for efficient small package deliveries.

---

Key Takeaways

  • Google's Position in Tech Race: Despite the quantum breakthrough being theoretical, it signals a positive direction for Google, potentially enhancing its competitive edge.
  • Quantum Computing's Future: While Google’s advancements are noteworthy, commercial applications remain years away, heightening skepticism about immediate financial benefits.
  • Health Insurance Sector Risks: The murder case may catalyze further regulatory scrutiny and public distrust in health insurance companies, which could impact stock valuations and market dynamics.
  • Market Reactions: Investors should remain cautious and informed about the ongoing developments in both tech innovations and health care regulations.

---

Final Remarks The episode encapsulates significant developments in the tech sector, especially with Google's quantum computing advancements, while also delving into the repercussions of a high-profile murder case on the health insurance industry. It reflects the intricate interplay of innovation, market speculation, and regulatory landscapes shaping investors' decisions.

Written by AI. May contain mistakes. Listen to the episode to check what was said.

Hear the part that matters, and keep it.Open this episode in VO. Double tap your headphones to save a moment as you listen.
Get VO free

Transcript

Automatic transcript. May contain errors.

0:00Live from the Nasdaq market site in the heart of New York City's Times Square, this is Fast Money. Here's what's on tap tonight. Gaga for Google shares of Alphabet surging after a major breakthrough in quantum computing. What we know about how this technology could change everything. Maybe. And the suspected shooter of the UnitedHealthcare CEO raging ahead of his first court appearance today. The latest updates on the case and how last week's events could lead to more scrutiny of the insurance sector. Plus, Walgreens and talks to go private again. Boeing restarts production of the embattled Maxjet.

0:32and Amazon's delivery drones finally take off in Phoenix. The details on all those stories coming up. I'm Melissa Lee coming to you live from Studio B at the NASDAQ. On the desk tonight, Tim Seymour, Steve Brasso, Guy Adami, and Julie Beal. We start off with Google's groundbreaking achievement. The tech giant announcing its quantum chip Willow computed a calculation that normally takes 10 septillion years. What? That's a lot. Or 10 to the 25th power. In just under five minutes, quantum computing is hailed as the next frontier in uber-high technology. Some hope it can provide answers to everything from drug development and space travel to the origin of the universe.

1:09But so far, there are no real-world applications. Still, the breakthrough sent shares of Alphabet surging more than 5%, adding nearly$120 billion to its market cap. Does this milestone give the mega cap a leg up in the big tech race? Did it make sense that we added so much in market cap to Google for a technology that has no commercial application yet? Guy. Not necessarily. However, I think what it shows is Google's not as far behind the eight ball as the market thought a few months ago. And the fact that they're probably still somewhat in the pole position and on valuation, you can make a case still despite today's move.

1:42And I think that 191 and three quarter level that we traded up July is in the crosshair. So good for Google. So obviously there have been some missteps, not necessarily from them, but the market around them. But I think people realize that if they want value, Google's the place to be. What is that hockey metaphor about the puck? Skating to the puck? Exactly. Is that what it's doing here? Well, I think our audience at home would like to know what you think is going on in the world's most famous arena with the Rangers. I doubt it. Because it's been a tough ride. But Google's more important tonight.

2:09And yes, they are. I actually think it is warranted. Not because, as we've all just said, it's not that Willow, whoever's naming these chips, is going to be a real term dynamic to take on NVIDIA or AMD. But it's a reminder where Google sits in the middle of some really exciting tech verticals. And then as the Baird note that we prepped some of this with, it says, you know, it's the largest advertising company in the world. It is certainly front and center as it relates to search and digital ad. And everything in their core business is A-OK. And it's getting bigger and bigger. But then you are in cloud compute.

2:42You are in areas where I think Google, you're reminded at 21 times forward in a world where all of their peers are now trading at multiples that are probably 20 to 40 percent higher than they were five years ago. Google's at the same multiple and it probably should be and it could be higher than some of the others. Do you think that we're giving them a tremendous birth? If this were talking about AI, we'd be saying it was pixie dust, right? I mean, think about it. Do you think you're giving them more of a wider berth? No, I think it's great, but I think guys started off the right way. Where are they going to use it?

3:19Or your entrance to the show, where are they going to use it? How are they going to monetize it? I think if this was AI, we would have been saying a host of headwinds towards this right now. So maybe it's not pixie dust, but where are they going to monetize? And you know who's been at the head of this and who was at the head of AI? IBM was at the head of both. It's outperformed Google on a year-to-date basis. It's quietly doing everything that everyone else is doing, not in a glitzy fashion. So I think that this run-up wasn't too much. That's what you started the show with. I think it was a little too much, and I think you're going to start to see a fade.

3:55Or maybe this underscores the value of Google, Julie, for the things that are not in the valuation. And this certainly was not in the valuation. I mean, this is early. Talk about early stages. is Google has a six-step milestone roadmap for quantum computing. This is milestone number two. So it is very early in the pathway, but it just shows that there is something in its back pocket. Yeah, absolutely. I think this is really much more of a reflection on valuation than being able to handicap when this technology is actually going to be economic. It's so much more about, hey, I have missed out on some of these rallies and these other AI names.

4:31I need confidence that Google isn't going to get completely left in the dust, particularly since a lot of AI chatbots have an existential threat to their search business. And so it's really critical for investors, especially longer term investors, to get confidence that they are going to be still in the mix and that they are working on delivering something that can support and eventually overcome their key search business, which is really where everything hinges. Is this your favorite Mag7 in stock, Julie? I think so. I think people forget that so much of the strength that we see in open AI really originated at Google.

5:10And that talent is really pretty critical. So I think it's pretty underappreciated. I think its core business is among the strongest that it's trying to defend. But I do think that it is in the most peril in terms of what can happen with more of these chat bots and more search being done away from them. Yeah, I think that's fair. I mean, And if you had to rank them, well, just the top two, I think it's Facebook, Google, just in terms of being able to wrap your head around evaluations. And, you know, the stock moves have backed that up. I mean, some of these other names are obviously great stories, but some of these other names are trading at excessive multiples, to say the least.

5:44Yeah, Tim. I just I think you you've had this debate for six months, really, is AI or maybe it's been a year has shifted into overdrive where Google sits. And every time there's a challenge to Google. Look, the biggest challenge to Google right now is probably really for the first time, and I'm not sure how big of a challenge it is, is on the antitrust side. And so just some of the dynamics that I think we're running into. But it's not that Google is not a leading-edge technology company with, you know, it's the greatest incubator in the world. What are you doing to monetize that? You know, what do you put on some of those numbers?

6:13I don't know. But all the core businesses to me, they're in the most exciting growth verticals right now. Why wouldn't you want to be in this name at 21 times forward when, in fact, again, And the range around the competitive landscape is probably double that in terms of valuation. Just distilling what you said before, Grasso, you're choosing IBM over Google. You're choosing IBM over NVIDIA. Well, I think NVIDIA, right, so NVIDIA's top clients are its top competitors. So the writing on the wall is there. Not that I don't think it can go higher, but I think that it's probably run its course right now and needs to pull back.

6:50Google, would I choose IBM? I think IBM has executed poorly. So I would choose to replace the IBM CEO and then get a little bit more growth here. And that seems like the year of replacing CEOs. I don't know. I think that they've done a poor job. On paper, I think they're better than Google right now. But Google, to Julie's point, really has to show what they're capable of doing. And they have 85 percent of search. They need another trick. All right. For more, let's bring in Fast Money friend Gene Munster of Deepwater Asset Management. Gene, I don't know about the subtillion stuff and, you know, all the zeros.

7:30What can this do? Drug discovery and other things. Is this too much to afford, you know, Google's market cap today for what this could be in however many years? I'm in the camp, I think, consistent with what most of the panelists said, which is this is probably too much for today. I agree with Guy that this is more of a validation point for Google's tech. But this, just to put it in perspective, they started this Willow project 12 years ago. And so the potential around this being commercialized is probably 10 years away. And so it's still a long time. It does speak there is a piece where the stock should have been up today out of guests a few percent because I think it does speak to Google Invested in the right areas for what will be continuing tech acceleration in the decades to come I mean this is a Google investor is asleep Well at night similar as Waymo is asleep.

8:27Well at night business doesn't get a ton of attention But I think collectively Melissa I would have expected the stock to be up a couple percent today not 5 % Gene, I love when you agree with me, so thank you. I'll ask you this question then on the back of that. Who should be worried about this? I saw in your notes probably not NVIDIA, not AMD yet, but somebody has to be. Yeah, I think, you know, there's some of the other quantum companies. There's private companies on that side. But I think on the public side, you know, the worries are probably because this, again, is so far away. I think the piece that the rest of the MAG-7 needs to be contemplating here, and NVIDIA needs to be thinking about is just what are they doing to have some sort of position within quantum computing.

9:11It is, it's theory right now, but I think you have to pursue that theory. Similar to when aviation was theory before we got flight. I mean, all of these things go from projects from the lab. And so I would say the potential losers are the companies that aren't doing that. And I think Google is standing alone right now within the MAG-7 in terms of their investments in quantum. So you said 10 years away from commercialization. And what do you think commercialization could be? What is the field that could benefit the most from quantum computing? I mean, it's as simple as AI. I mean, just the peer, you went through the numbers, basically going from an eternity to five minutes.

9:53I mean, it's hard. This is the kind of stuff, it's called superpositioning. It's hard for me to wrap my mind around the improvements in compute speed. And so I think probably the biggest beneficiary is just everything that's AI. I mean, ultimately, you have a company like NVIDIA. If Quantum moves from theory to actually a production product, they need to have an answer down the road. And so the question, who's going to be impacted, what's the use cases on these, I think AI is probably front and center. And within AI, probably healthcare is one of the biggest areas, initial areas. Jean, great to speak with you.

10:28Thank you. Thank you. Gene Munster, Deepwater Asset Manager. We were just showing the chart of NVIDIA. And remember, NVIDIA fell yesterday in the back of the news of the China investigation. So it's interesting that it doesn't, you know, it can't catch a bid today. And then we have this interesting supercomputer news. Well, it's certainly, this is a trade today about tomorrow. NVIDIA arguably could be, you know, yesterday's trade today. I don't know. But I would look at the semiconductor space. You cannot single out NVIDIA. I would look at semis, which today hit another important relative value underperformance to the S &P, which takes you almost all the way back to February of this year, which was when they were going to to the moon.

11:07So it's, you know, again, a relative value chart looks a little bit like a reverse head and shoulders on the way down. We've got some breaking news out of Washington. Megan Cassell's got the latest. Megan. Hey, Melissa, so Scott Besson, Trump's pick to be the Treasury secretary, was on Capitol Hill once again today meeting with senators ahead of his nomination and leaving a meeting with incoming Senate Finance Chair Mike Crape. Our Karen James, our producer Karen James, caught up with him and got a chance to ask him a couple of questions about his priorities and about this idea of a shadow Fed chair.

11:36Take a listen. As the president said on Sunday, and I am in complete agreement with him, that Jay Powell will serve out his terms and leave the building as Fed chair on May 26th. Now, this is interesting for what he said, but also, Melissa, I would highlight for what he hasn't said there. He said that essentially they will not be firing Jay Powell before his term is up, sort of reiterating or reemphasizing what President Trump said, President-elect Trump said on Sunday in that interview, saying that he had no plans to replace Powell. But Bessent, of course, is the Trump advisor who initially laid out that idea of a shadow Fed chair, saying that he would advocate for nominating someone very, very early to replace Powell so that person could, in effect, become the one who lays out advice and who the market is listening to rather than Powell.

12:25Even while Powell is still in office, Karen said to him there, how do you feel about a shadow Fed chair? He says that Powell will stay in office until the end of his term, but wasn't completely putting the idea to bed there. So a lot to read into this, Melissa, but at least for now, Powell can think that his job is safe. All right. Megan, thank you. Megan Casella. A key inflation report out tomorrow. CPI may interrupt the Fed's rate cut plans. November Consumer Price Index out before the opening bell. Dow Jones expects the number to climb by a tenth of a percent from October. CNBC senior economics reporter Steve Leisman is here.

12:58On the desk. On the desk. In the house. He's playing live. Live, exactly. Stella Blues on CPI. It's a plug, right? Unsolicited plug. First of all, I mean, to the comments, he still he craftily did not really answer. He didn't say no shadow. Exactly. He just said Powell's going to serve the term, which we knew already. Well, we didn't know that already. I mean, I guess he kind of ruled out. Well, he ruled out the idea of maybe replacing him having a big fight over the idea, which is what the president ruled out. But they have not ruled out the idea that they could appoint this person ahead of time and kind of take some of the what is it done?

13:38Cut them off at the knees, so to speak, in the sense that if your shadow Fed chair says something about the future of policy, it removes the forward guidance tool, in a sense, from the Fed chair. Now, I don't know if they're going to do that. He was the guy that mentioned it. He did not specifically deny doing that there. And I guess if they get to a point where they're angry at Fed policy, they can do that. Right. Back to Fed policy. Is this going to change the trajectory of the Fed in December? I think it's a very consequential number tomorrow. And for y 'all traders around the desk here, I would say.

14:14And the next day, you've got to take the CPI and the PPI together. The market is very good at trading it in some, but in its pieces. So you want to be careful. Like if you get a hot CPI, but a cool PPI, we put them together. whether we create the PCE and that's the thing the Fed cares about. And by the way, that is the expectation. Sort of the number you read earlier, that 0-3, fourth one in a row, core CPI. So that's the notion. Guys, do you have that other chart that I made ahead of this conversation here, which is the one with the bar chart? And what you see is kind of an interesting story.

14:47You can see you're – no, not that one. That is a bar chart. It is a bar chart. I'm so sorry. The one about the CPI, the core CPI one, we're having fun here, ladies and gentlemen. Maybe it's not available. It shows the story of high earlier this year, came down in the middle, got everybody excited it was coming down. And now it's kind of back up about halfway. I don't know if we can do that. Do we have it? You're pointing. Well, she's pointing at me. This is what I do. While we wait for this chart, and I'll defer as soon as it goes up there, but we had small business confidence that came out today.

15:17Through the roof. It's highest in three and a half years. And they talked about the inflation, the wage components, all they talked about. They basically said their prices are highest that they've been since March, and they're probably going higher. It's great that they're confident. Obviously, it bodes well for small caps and all kinds of things we talk about. But this is another ingredient that says inflation's not coming down. It's going higher. Well, a couple things. First of all, be a little careful with the small business, NFIB. It's a very Republican-leaning group. Oh, okay. There's the chart, by the way.

15:42Oh, well, there you go. There's the story. So look at that. It was high before that somebody freaked out, those parts on the left there. Then everybody got really happy and comfy in the middle there. And now we're like, oh, is inflation stalling here? And that's what's going to add to the conversation. So be a little careful with that. It has been this absolute surge. I think maybe Democrats ought to think about why business leaders are reacting as if a boot was taken off their neck. I think that's not necessarily the best way to run your economic policies in the country. And you get that. And that creates this possibility of a surge in business spending and capital spending.

16:17And that creates some concern. But the Fed, I don't think, Tim, can make policy based on the expectations of people for policies that may or may not be enacted down the road. Sure. Okay? But this is just another ingredient of many that have been in the stew, that inflation isn't getting better. You know, what we hear from companies anecdotally throughout the earnings season was there's price pressures. There's certainly service price. We saw it in the ISM, and we've heard from corporate America. Okay. Did you see the unit labor costs today? Of course I did. Did you see the productivity numbers today?

16:55Did they make you smile? Yeah. Well, you know, I'm always happy to see good numbers. Look, if we have high productivity, if we have low unit labor costs, we can run the economy a little hotter without inflationary pressures, okay? And, look, I am getting a lot of commentary from people, especially over this thing, that are saying, Steve, you're out of your mind to think that I still think they have another quarter of recalibration in them. But now we can go to that four-bar chart, the one with four bars. That was a good chart. Is Sandy going to hate me after this? Well, too late. Maybe he already does.

17:30But if you said the Fed's rate path chart, then that chart would come up right away. Thank you, Melissa. Perhaps afterwards you can write the instructions for me. I will try. He said he had nothing but love for me in my ear. But OK. So let's talk about this chart. Yes. Let's talk about it. Let's talk about it. What we see is that 87, what is it, 84 % number is too far away. 85 % number, percentage probability of a cut coming next week. Then everybody thinks they take a pause. Now, the thing you have to realize is the next two bars represent the probability of the same quarter point cut. So over the course of March and May, they think another quarter is laid in.

18:05So that's 50. Now, I have another chart, ladies and gentlemen, which is the December 25 Fed Funds Futures Chart. I'm glad he named it. I know. It may smell really easier for the first year. Makes it easy to find it. Let's talk about this. This is 372. Let's do the math. That's 28 points to 400 and add another 60. So they think there's another 80 basis points built in between now and next year. We get perhaps 50 by March and then you're done. So the idea is the Fed does this other quarter and then maybe it does two other quarters over the course of next year. That's where it's kind of a proxy for the terminal rate.

18:46But if you go down to 26, you get other answers. But that's a good proxy for the terminal rate. What's interesting is from what I think matters to you guys, the market knows all this. The market has internalized all this. It doesn't seem to care all that much. I think that I did the math. You're up 7.7 % at the top from the election. Now you're up, what was the number I just calculated? 5.8 %? Yeah, 5.9 % since the election. You gave back two percentage points. So the market seems to be okay with this, Melissa. I think, are you upset by this? He doesn't look upset. But do you ever look upset? You always look happy.

19:24I'm a happy guy. No, listen, you know, I think Jerome Powell's done a remarkable, a couple missteps here and there, but that's probably not the, he's done a remarkable job. The messaging has been good. I mean, we'll see how we get through this. I know we've got a couple. We may have, there's two dissents that I'm thinking about. Bowman, maybe again? the Fed governor. And now Ms. Hammack, the new Cleveland Fed president, she was a little bit on the fence in the sense that she said, I could see another quarter point cut between now and January. So she was like, do that quarter either now or in January.

19:55So I don't know. You might get a surprise a week from now, in which case, I think you do get the extra quarter, though. I think they're still recalibrating. Steve, thank you. Thanks for all the charts. It was really wonderful to come down here. Thank you. I didn't really believe that, but we'll see. This doesn't happen when I'm remote. I get the charts up right away. Coming up. So you're blaming us. It's a warm feeling today. I'm not blaming you. Just talking about... These boots are made for walking right into the private equity market. This is for you, guy. Walgreens boots. Get it? Walgreens surging reports of a P.E.

20:25deal, what it could mean for the beaten down pharmacy company that is next. Plus, Boeing takes off. Shares leading the Dow as Max production goes back online. What it means for delivery numbers and how things look one month after the machine is strike. Don't go anywhere. Fast money is back in two.

20:46Welcome back to Fast Money. Shares of U.S. steel dropping nearly 22 percent at its lows after a report that the Biden administration is set to block its acquisition by Japan's Nippon steel. Nippon saying in reaction, we're confident that our proposed partnership is the best path forward to secure the future of U.S. steel and that we've engaged in good faith to underscore how the transaction will bolster American economic and national security by countering the threats posed by China. The White House just issuing a statement saying Biden will continue to see what the CFIUS process yields and that they haven't received any recommendation yet.

21:17Shares of U.S. steel down nearly 30 percent since the deal was first announced almost a year ago. So it's amazing that people continue to be surprised at this because it's been talked about so much. But there was sort of a glimmer of hope for some reason that Biden in the 11th hour would actually let the deal go through to save U.S. steel. I think it's a buy on the weakness, because if you think about it, what has Trump said? He's against the deal as well, but he's going to have tax incentives and tariffs to deal with it. That's going to pop the stock. So all of this is a buying opportunity, in my opinion.

21:50It's interesting. It's a day when you saw POSCO and some of the other global steels rally a little bit. And it's not necessarily that the fundamentals in the steel sector are that great. In fact, that's really the story here. So, you know, if there is an outside bid where there's some strategic value that's applied to the U.S. business, You know, it's not in the best interests of shareholders to see this deal not happen. In other words, this deal should happen and it would be voted on by shareholders, but higher powers. Meantime, shares of Walgreens notching their best day ever on reports of beating down pharmacy chains exploring a deal with private equity firm Sycamore Partners.

22:23Walgreens had previously tried to go public in 2019 when it was worth$55 billion. It closed today with a market value of just over$9 billion. What a decline. I mean, they've got to stabilize the retail pharmacy business, which has been a car wreck. Disaster. Now you want to play a little stock market here because this is a name that traded. It was a 32-year low, I think, in the name recently. And obviously, you got the bounce today on probably five times normal volume. The question you have to ask yourself, you know, you want to play it for another 25 or 30 percent, which doesn't mean it's fixed by any stretch, but you might be able to get that based on this news and based on probably the short interest.

22:59So, again, not fixed, but the stock might be a buy here in a pretty major way. Julie, what do you think? Yeah, it's a really difficult situation. It's, you know, the amount of value destruction that you've seen here is pretty substantial. And, you know, Sycamore, being a great firm, has not typically done deals quite this large. And it's a big ship that it has to turn around. I do think there will be continued interest from other parties because it's true you can split this business off. And it probably has some of the parts that's compelling. So I think it's definitely in play. But the fundamentals of this are really tough.

Read the full transcript

23:33It's probably going to limit the buying pool. This is a classic private equity dynamic because there's a balance sheet here that's unsustainable. There's a debt problem that if you're an equity player, you're like, oh, wow, there's really an opportunity. It's oversold. You know, they're going to fix their business. There's a debt overhang that's a big problem here. And I think this is exactly where private equity will work some magic. All right. Coming up, Boeing back at it. the company restarting production of its 737 Max planes one month after the end of its machinist strike. Will the news jumpstart the stock further?

24:01And a violent outburst from the UNH CEO murder suspect as he's brought into Pennsylvania court. The latest details on that and how this is all casting a spotlight on other players in the health insurance space. You're watching Fast Money Live from the Nasdaq MarketSide in Times Square. Back right after this.

24:25Welcome back to Fast Money Stocks in the Red as investors awaited tomorrow's inflation data. The Dow falling more than 150 points now on a four-day losing streak. The S &P and Nasdaq also down about a quarter of a percent, but the Nasdaq did hit a new intraday record early in the session. A federal judge blocking supermarket giant Kroger's$25 billion merger with Albertson siding with the FTC. The agency arguing that the merger would eliminate competition in the industry, leading to higher prices for shoppers and reduced bargaining leverage for unionized workers. Boeing popping 4.5 percent today on news that the company restarted production of its 737 MAX a month after the end of its machinist strike.

25:02The company also saying it delivered 13 planes in November, down from 14 in October when the bulk of the strike occurred. And GM shares jumping after hours following the automaker announcing its decision to no longer fund its robo-taxi effort and instead focus its autonomous and assisted driving development on personal vehicles. And S &P just downgrading Intel to triple B rating due to a slow recovery in its business. That is the lowest investment grade rating from the credit agency. There's a lot of roads there. Yeah. Where do you want to trade? I'll trade Boeing. And let's be clear, you know, 13 is nothing to do cartwheels on on deliveries, but down from 56 year over year.

25:41Nine max, I think, down from something in the 40s. It's a case where really to believe in Boeing, you have to believe in some beginning of a normalization process in terms of production. Because if they are anywhere near, if they are three quarters of where they were on last year's production schedule, they're going to be cash flow positive. That's the story. This is a company. It's not as bad as cheap. There's no profitability right now. So, I mean, you can depend how you want to look at this one. But I am of the view that this is a story you want to own here. And I've said that for a year and been wrong.

26:11And you've said that more recently, Guy. I have, and it's been wrong for months and months. But since that secondary, a month and a half, 143, I mean, you've had this stealth rally that's basically been very quiet. And all of a sudden you find you wake up, it's$164 stock. And, you know, I think it's right up against 150 day moving average, which is somewhat problematic. With that said, you know, you get through it and we could be talking about Boeing in the mid 180s very easily by early next year. And nothing has effectively changed other than the stock price. So I think for a while, at least, the bad news is out of the way.

26:44GM getting rid of cruise or stopping the spending, that's a billion dollars once the plan is completed in money that it won't spend on cruise, which is a good thing. It's a good thing. And GM has actually been one of the shining spots within the automotive industry. Everyone compares this to this massive run that Tesla had, but you only really have to compare it to Ford. And I'd rather GM than Ford. But also when you look at Intel, I think Julie said some of the parts in her earlier stock. Why isn't Intel a some of the parts story? I know that we've tried to make it that. CEO gone. There's got to be a bid in this at some point.

27:22Right? I mean, I feel like I'm holding my breath. You look at the chart. Timing is everything. You look at the chart. But I will tell you one little thing. I know you want to go to Julie. Boeing, when you look at that, what do you think Doge is going to go to town with Boeing? Talk about the inefficiencies in the contracts. 37 % of their income is from government revenue. They're going to go to that with a hacksaw. Coming up, murder suspect Luigi Mangione yelling at reporters ahead of his extradition, hearing the latest details on his motives and how the entire health insurance space could be under scrutiny.

27:55Fast Money is back in two.

28:05Welcome back to Fast Money. New developments in the murder of the UnitedHealthcare CEO. You're looking at an agitated Luigi Mangione being forced into a Pennsylvania courthouse while yelling at TV cameras. The 26-year-old suspect is facing extradition to New York, where he faces a murder charge in the killing of Brian Thompson. Bertha Coombs is here with the very latest on what we know and the growing backlash for those involved in the capture of the alleged murderer. Bertha. That's right, Melissa. 26-year-old Luigi Mangione remains in custody in Pennsylvania tonight after a judge in Pennsylvania again denied bail following the preliminary extradition hearing.

28:39His public defender told the court that Mangione is contesting extradition. Manhattan District Attorney's Office says it will seek what's known as a governor's warrant to push for that extradition. tradition that followed an outburst from Mangione ahead of the hearing as he was escorted in. And completely out of touch and insult the intelligence of the American people. It's a serious experience. He was saying there that it's completely unjust. Now, while New York officials have not formally shared a motive, senior law enforcement officials tell NBC News that Mangione had a three-page manifesto with him when he was arrested yesterday at a McDonald's in Altoona, Pennsylvania, in which he decried large corporations, the health care industry and UnitedHealthcare in particular, with statements including, quote, I do apologize for any strife or traumas, but it had to be done.

29:30Frankly, these parasites simply had it coming. And a note saying he acted alone, quote, to the feds. I'll keep this short because I do respect what you do for our country. To save you a lengthy investigation, I state plainly that I wasn't working with anyone, unquote. Officials are concerned that we could see others act out, given the backlash that we've seen against employees at the McDonald's, where they had called about a tip about Mangione's location yesterday. And the Altoona police say the officers who arrested Mangione and the department itself have been receiving threats since yesterday as well.

30:09As a deputy police chief says, this is, quote, A very polarized case. Melissa, it's really touched a nerve for many people who are frustrated with the U.S. health system and with claims denials that often frustrate so many as they're trying to get care for themselves and their loved ones. Yeah, I think everybody's got a health care story, Bertha, and that's what's really behind the animus here. Bertha, thank you for covering the story. Bertha Coombs, let's get more now with John Ransom, Managing Director and Director of Health Care Research at Raymond James. John, great to have you with us. You say that, you know, the health care industry has always been unpopular, that United Health Care in particular has worked through these periods in the past.

30:48But wouldn't you say that this is a little bit different? I mean, we haven't been through a period where the CEO of a health care unit gets assassinated in the streets of Manhattan and people are cheering. Sure. I mean, the old saying that politics is downstream of culture. You know, the culture right now would paint these a bullet, you know, bull's eye on these guys to use a bad metaphor. I think the uncertainty, if you look at the Gallup polls, it's gotten more unpopular among Republicans. If you look at the polling, it's kind of fascinating. So we don't know who's going to be occupying these seats next year in Congress.

31:22But, yeah, this industry, particularly the Medicare Advantage guys, were beat up pretty badly by the Biden administration. Investors think the incoming Trump administration will be a little kinder. But I think the bet is a little bit hard to make because you don't know who's going to be occupying these seats. And also, you do have a more populist party, and the industry is not as popular as it used to be. Yeah. What is the biggest risk to this industry? I mean, part of it is the lack of transparency. So to the extent that there could be forced transparency in the form of some sort of regulation, would publishing denial rates be that detrimental to the industry?

32:03I mean, as you sort of take a look at the risks, what are those risks in your view? Well, what's interesting, let's take CVS. You had an eloquent money manager on a couple weeks ago. CVS's medical loss ratio in their Medicare Advantage book is up from about 85 percent to over 95 percent. So CVS is actually spending 10 points more and they're losing their shirt. They're losing billions of dollars in Medicare Advantage. So if you look at the business risk, it's the fact that medical costs have exploded. Now, of course, that hasn't bought the industry any goodwill. But the truth is these insurance companies that people don't like are losing their shirts on Medicare Advantage and also on some, you know, CVS also is losing a billion dollars in the exchanges.

32:47So the risk is that that's the risk. It's the medical loss ratio. I think the legislative risk, and this is where I think there's a debate, is have we overused AI for things like prior authorization? Can we do things to make appeals processes more transparent? You know, could companies be easier to work with? Absolutely. And that's the thing, I think, where there could be some meeting of the minds. I mean, you know, when you get a claim denied, I can't think of anybody who's come away from that saying, oh, gosh, when I appeal, that was just a wonderful process. And I think lastly, like AMA is on this warpath on prior authorization for prescriptions.

33:26And that used to be in place for very expensive drugs. But again, this trend has increased. Prior authorization has grown and grown. So, you know, I talked to a guy yesterday. He said, yeah, every one of my prescriptions is prior off and has to be appealed. So I think that friction and maybe the overuse of AI. United bought a company called Nova Health and I think replaced some of the human engineering with some robotic engineering. And that's where I think there should be a healthy debate because maybe that has gotten out of control. So there is an aspect of AI gone wrong. I mean, we, you know, investors are touting AI as a great growth trade, right, on one side of the ledger in the markets.

34:01And then here we are in an example of an industry that has embraced AI. In theory, it should reduce costs tremendously because of all the paperwork. And yet it's backfired in this case. Do you think the companies are willing to roll back? Let's think about good AI. Let's say I'm a United customer and they look at my I got discharged from the ER for 2 a.m. At 2 a.m., I missed a prescription. I've got a police record. I've got something on my file. They should say, let's get John some help. You know, predictive analytics, get John some help. Now, that's using large language models to look across all these data sets, predict where people need help, intervene before they crash.

34:37That's a great example of where AI should be. But, yeah, did we overdo it on prior off? That's the debate. I'm not saying we did, but I think that's where we need to have a debate. John, great to speak with you. Thank you. All right. Thank you. John Ransom, what do you think? Well, John's right. I mean, the good AI is right, but we're light years away from that. We're on the other side of that spectrum. It's like, how can we basically, you know, ding this claim and, you know, not fill this? So that's the problem. That's why people are upset. It doesn't justify anything, by the way. But with that said, I mean, UNH, despite the fact that competitors have had horrible stock moves, it hangs in there like a champ.

35:16So you sell this one at your own risk, I think, here, Mel. Yeah. Julie? Yeah, I think it's really much more a reflection not just of claims, but so much medical debt is really, you know, putting people under. and into bankruptcy. That's the number one reason for bankruptcies is medical debt. And I think it's just a reflection of how broken the system is in terms of we pay more for our health care and we have worse outcomes. I really think it's a broader reflection than just claims processing. But yes, I agree. This is a great example of where AI maybe isn't perfect. Coming up, it's a bird, it's a plane, it's a drone dropping off some Amazon packages.

35:55How the e-commerce giant is hitting the skies once again. and if the program can finally deliver. That's next. Plus, how options traders are handling the drop in HIMS. Shares down nearly 6 % in today's session. So what is behind that? We'll discuss that when Fast Money returns.

36:16Welcome back to Fast Money. Amazon shares failing to lift off today. It comes as the company is officially kicking off its drone delivery program in Arizona. The e-commerce titans saying its new fleet of drones is 40 percent quieter than the older versions, which saw some pushback in other test sites like College Station, Texas. Our Kate Rooney is live in Phoenix with the very latest. Hey, Kate. Hi, Melissa. So Amazon first started publicly talking about this drone project about a decade ago. They are officially now using drones to deliver packages around the Phoenix metro area. These are meant for smaller items.

36:49Think of things that fit into a shoebox. They have to weigh five pounds or less, and then they drop from a drone. It's about 12 feet in the air. You pay$10 or so extra for a drone delivery to get some of these items faster. There have been some changes in design over the years. They did cut the noise, they say, by 40 percent, doubled the range, and then through testing have figured out some things. They talked about how to avoid dogs, which you can imagine like to chase these drones. Amazon executive David Carbon, who spent nearly two decades at Boeing, tells me managing airspace has really been one of the biggest challenges.

37:21They did get FAA approval in October for the latest MK30 drones. And the site here is integrated directly with one of those sub-same-day fulfillment centers, which is right nearby. And that's how they plan to scale quickly. I'm told they're going to be rolling out into new cities next year. The goal, they say, it's 500 million deliveries per year within 30 minutes or less. So far, they've only done thousands of deliveries, they say. And there's a lot more competition out there. Walmart is among those rolling out their own drones in the area. Back to you, Mel. Kate, those drones look big. I mean, how much can they actually carry in one go?

37:57So it's one box. It's got to be smaller than a shoe box. So these are things you need immediately. They use the example of, say, you're cooking and you forgot an onion. And so it's those small things. Health care is really popular. We saw a Jenga box, the game, get delivered. So they're not the bulk items. It's sort of the last-minute item. And they talked about this really not being right for everything. Not everything is going to be delivered through a drone, but it is that sort of last minute thing. They hope at some point that it's kind of on par pricing wise with trucking. But there's some metro areas, too.

38:26You can imagine it's actually easier. The network is set up better to have trucks out there, whereas more rural areas and even some of the suburbs here might actually work for a drone. But you also kind of need a yard. You need a sort of landing pad where you can have a box drop down. This would be really hard to do in a major city. And you got to hope that you don't have a pet or small children underneath the box. That was one of the biggest things. The dogs. They said, actually, the engineers thought of everything. And apparently none of them were dog owners because when they went out to actually test in College Station, the dog thing kept coming up again and again.

38:59So they had to figure out ways that they could hover without landing if there was a dog and kind of abort the mission and go back. But they say actually not landing is pretty common because you could have a kid who runs out. But safety is a huge headline risk. If there were some sort of issue, you could imagine that would really set this program back in a big way. Kate, thanks. Kate Rooney. Yeah, safety. But you can get your Jenga right away. You've got to really want to have an urge to play Jenga guy. I know. I mean, there's going to be a Jenga emergency. You know, you never know. If you really need it, you go to Uber.

39:29You go to Uber delivery. It only holds five pounds right now, right? So you can't get a really big Jenga set. You can't get a small one or less. I've never played Jenga. I've never played Jenga. You pull the stick out so it doesn't collapse. And then you say Jenga when you screw it up. Sure. I don't know how that works. Jenga!

39:48A big drop in HIMSS as traders embrace for major court ruling next week. What the decision could mean for the company and how the options fits are positioning ahead of it. More Fast Money in two.

40:05Welcome back to Fast Money. Shares of HIMSS and HERS falling today as investors anxiously await an update on the FDA's reevaluation of its decision to take Eli Lilly's terzepatide off the shortage list. That update expected next week could have a major impact on the effect on the ability of the compounder to actually make those compounded GLP-1s. And that would hurt its business. Options traders are betting that the ruling may not go in HIMSS's favor. Mike Coe's got the action. Mike, what are you seeing? We see very high implied volatility. Big moves anticipated in HIMSS. By the end of next week, we see very high implied volatility there.

40:39Moves of more than 16 % are implied. And we saw a lot of put activity. Actually, it was the December 27th 29 strike puts that saw the most opening activity, actually. Purchases of more than 3 ,300 of those took place over a 20-minute span between 1.40 and 2 p.m. this afternoon. Buyers of those are obviously betting that the decision could be unfavorable favorable and that the stock's decline that we saw today could continue. All right. You know, we've seen this roller coaster of the Hems and Hers stock. Every single time there's like a little blip of the possibility that it might not be able to compound.

41:14It's so fragile, that business model. But at some point, it's an inevitability, isn't it? I mean, based upon what we're expecting from these drug companies and the ramp and everything that we're hearing from them, this was an$8 stock at the start of this year. So, I mean, you know, if I'm an option player, depending, I'm not sure I want to buy the long-term vol on this, which is very expensive, but I think it's going to happen. 15 to 35, basically, in a heartbeat from, I think, late August until now. I mean, I think these are the right strike. I mean, 25 is a 50 % retracement of that. They may be a little expensive, but you get that vol will kick in for you if it starts to move to the downside.

41:50It's got a short interest of 15%. It's up 246 % year-to-date to both of my panelists on the side of me right now. So it doesn't need that much to send the stock higher. I've been doing this 18 years. Not yet. If we make it in January of next Final Trades. Sorry.

42:23time for the final trade julie beal notice some insider buying on a name i already like something to pay attention to tim willow or no willow i like google whether it's the valuation whether it's the growth it's given you, stay there. Stephen. IBM at the forefront of quantum computing and AI. Get an activist in there. IBM. Guy. I think Willow is the name of Michael Corinthos' wife in General Hospital. Not a good person, as it turns out, if you've been watching GH. That's a really strange poll. Is this current GH? Current GH. Is there current GH? It's still on. It's been 30 years for me. Luke and Laura.

43:04Do you have a trade, please, sir? Look at the Gilead. Sir? Look at the Gilead. Quick! Mad Money starts right now. All opinions expressed by the Fast Money participants are solely their opinions and do not reflect the opinions of CNBC, NBCUniversal, their parent company or affiliates, and may have been previously disseminated by them on television, radio, internet, or another medium. You should not treat any opinion expressed on this podcast as a specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion. Such opinions are based upon information the Fast Money participants consider reliable, but neither CNBC nor its affiliates and or subsidiaries warrant its completeness or accuracy, and it should not be relied upon as such.

43:45To view the full Fast Money disclaimer, please visit cnbc.com forward slash fastmoneydisclaimer.

From the publisher

Shares of Alphabet surging as Google unveils a ‘breakthrough’ quantum computing chip. What it means for the future of coding, and the areas of tech that could benefit. Plus A spotlight on the health insurance space, as the suspect in the UNH CEO murder investigation heads to his first court appearance. The latest details on his motives, and how it could all impact other players in the health insurance space.

Fast Money Disclaimer


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

More from CNBC's "Fast Money"

All 872 episodes
Google’s Quantum Computing Breakthrough… And Health Insurers In The Spotlight 12/10/24CNBC's "Fast Money" · 44 min
Listen in VO